Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 71

1.

Are intensive care physicians aware of dysphagia? The MADICU survey results.

Marian T, Dünser M, Citerio G, Koköfer A, Dziewas R.

Intensive Care Med. 2018 Jun;44(6):973-975. doi: 10.1007/s00134-018-5181-1. Epub 2018 May 8. No abstract available.

PMID:
29737377
2.

The Effect of Improved Dysphagia Care on Outcome in Patients with Acute Stroke: Trends from 8-Year Data of a Large Stroke Register.

Suntrup-Krueger S, Minnerup J, Muhle P, Claus I, Schröder JB, Marian T, Warnecke T, Kalic M, Berger K, Dziewas R.

Cerebrovasc Dis. 2018;45(3-4):101-108. doi: 10.1159/000487811. Epub 2018 Mar 13.

PMID:
29533960
3.

Introducing a Virtual Lesion Model of Dysphagia Resulting from Pharyngeal Sensory Impairment.

Muhle P, Claus I, Marian T, Schröder JB, Wollbrink A, Pantev C, Warnecke T, Dziewas R, Suntrup-Krueger S.

Neurosignals. 2018 Jan 25;26(1):1-10. doi: 10.1159/000487037. [Epub ahead of print]

4.

Increase of Substance P Concentration in Saliva after Pharyngeal Electrical Stimulation in Severely Dysphagic Stroke Patients - an Indicator of Decannulation Success?

Muhle P, Suntrup-Krueger S, Bittner S, Ruck T, Claus I, Marian T, Schröder JB, Minnerup J, Warnecke T, Meuth SG, Dziewas R.

Neurosignals. 2017;25(1):74-87. doi: 10.1159/000482002. Epub 2017 Oct 17.

5.

Pharyngolaryngeal Sensory Deficits in Patients with Middle Cerebral Artery Infarction: Lateralization and Relation to Overall Dysphagia Severity.

Marian T, Schröder JB, Muhle P, Claus I, Riecker A, Warnecke T, Suntrup-Krueger S, Dziewas R.

Cerebrovasc Dis Extra. 2017;7(3):130-139. doi: 10.1159/000479483. Epub 2017 Oct 3.

6.

Measurement of Oxygen Desaturation Is Not Useful for the Detection of Aspiration in Dysphagic Stroke Patients.

Marian T, Schröder J, Muhle P, Claus I, Oelenberg S, Hamacher C, Warnecke T, Suntrup-Krüger S, Dziewas R.

Cerebrovasc Dis Extra. 2017;7(1):44-50. doi: 10.1159/000453083. Epub 2017 Mar 4.

7.

Electrical pharyngeal stimulation increases substance P level in saliva.

Suntrup-Krueger S, Bittner S, Recker S, Meuth SG, Warnecke T, Suttrup I, Marian T, Dziewas R.

Neurogastroenterol Motil. 2016 Jun;28(6):855-60. doi: 10.1111/nmo.12783. Epub 2016 Feb 12.

PMID:
26871730
8.

Electrical pharyngeal stimulation for dysphagia treatment in tracheotomized stroke patients: a randomized controlled trial.

Suntrup S, Marian T, Schröder JB, Suttrup I, Muhle P, Oelenberg S, Hamacher C, Minnerup J, Warnecke T, Dziewas R.

Intensive Care Med. 2015 Sep;41(9):1629-37. doi: 10.1007/s00134-015-3897-8. Epub 2015 Jun 13.

PMID:
26077087
9.

2'[(18)F]-fluoroethylrhodamine B is a promising radiotracer to measure P-glycoprotein function.

Trencsényi G, Kertész I, Krasznai ZT, Máté G, Szalóki G, Szabó Judit P, Kárpáti L, Krasznai Z, Márián T, Goda K.

Eur J Pharm Sci. 2015 Jul 10;74:27-35. doi: 10.1016/j.ejps.2015.03.026. Epub 2015 Apr 7.

PMID:
25857708
10.

18FDG, [18F]FLT, [18F]FAZA, and 11C-methionine are suitable tracers for the diagnosis and in vivo follow-up of the efficacy of chemotherapy by miniPET in both multidrug resistant and sensitive human gynecologic tumor xenografts.

Trencsényi G, Márián T, Lajtos I, Krasznai Z, Balkay L, Emri M, Mikecz P, Goda K, Szalóki G, Juhász I, Németh E, Miklovicz T, Szabó G, Krasznai ZT.

Biomed Res Int. 2014;2014:787365. doi: 10.1155/2014/787365. Epub 2014 Sep 18.

11.

The strong in vivo anti-tumor effect of the UIC2 monoclonal antibody is the combined result of Pgp inhibition and antibody dependent cell-mediated cytotoxicity.

Szalóki G, Krasznai ZT, Tóth Á, Vízkeleti L, Szöllősi AG, Trencsényi G, Lajtos I, Juhász I, Krasznai Z, Márián T, Balázs M, Szabó G, Goda K.

PLoS One. 2014 Sep 19;9(9):e107875. doi: 10.1371/journal.pone.0107875. eCollection 2014.

12.

¹⁸FDG a PET tumor diagnostic tracer is not a substrate of the ABC transporter P-glycoprotein.

Krasznai ZT, Trencsényi G, Krasznai Z, Mikecz P, Nizsalóczki E, Szalóki G, Szabó JP, Balkay L, Márián T, Goda K.

Eur J Pharm Sci. 2014 Nov 20;64:1-8. doi: 10.1016/j.ejps.2014.08.002. Epub 2014 Aug 20.

PMID:
25149126
13.

Metastatic hepatocarcinoma he/de tumor model in rat.

Trencsenyi G, Marian T, Bako F, Emri M, Nagy G, Kertai P, Banfalvi G.

J Cancer. 2014 Jun 21;5(7):548-58. doi: 10.7150/jca.9315. eCollection 2014.

14.

Tumor-specific localization of self-assembled nanoparticle PET/MR modalities.

Hajdu I, Trencsényi G, Bodnár M, Emri M, Bánfalvi G, Sikula J, Márián T, Kollár J, Vámosi G, Borbély J.

Anticancer Res. 2014 Jan;34(1):49-59.

PMID:
24403444
15.

Body fat distribution and metabolic consequences - Examination opportunities in dogs.

Müller L, Kollár E, Balogh L, Pöstényi Z, Márián T, Garai I, Balkay L, Trencsényi G, Thuróczy J.

Acta Vet Hung. 2014 Jun;62(2):169-79. doi: 10.1556/AVet.2013.057.

PMID:
24334077
16.

In vivo application of a small molecular weight antifungal protein of Penicillium chrysogenum (PAF).

Palicz Z, Jenes A, Gáll T, Miszti-Blasius K, Kollár S, Kovács I, Emri M, Márián T, Leiter E, Pócsi I, Csősz E, Kalló G, Hegedűs C, Virág L, Csernoch L, Szentesi P.

Toxicol Appl Pharmacol. 2013 May 15;269(1):8-16. doi: 10.1016/j.taap.2013.02.014. Epub 2013 Mar 4.

PMID:
23466426
17.

Cancer cell targeting and imaging with biopolymer-based nanodevices.

Hajdu I, Bodnár M, Trencsényi G, Márián T, Vámosi G, Kollár J, Borbély J.

Int J Pharm. 2013 Jan 30;441(1-2):234-41. doi: 10.1016/j.ijpharm.2012.11.038. Epub 2012 Dec 14.

PMID:
23246780
18.

Imaging the migration of therapeutically delivered cardiac stem cells.

Gyöngyösi M, Hemetsberger R, Wolbank S, Kaun C, Posa A, Marian T, Balkay L, Emri M, Galuska L, Mikecz P, Petrasi Z, Charwat S, Hemetsberger H, Blanco J, Maurer G.

JACC Cardiovasc Imaging. 2010 Jul;3(7):772-5. doi: 10.1016/j.jcmg.2010.04.012. No abstract available. Erratum in: JACC Cardiovasc Imaging. 2011 Mar;4(3):314.

19.

Multispecies animal investigation on biodistribution, pharmacokinetics and toxicity of 177Lu-EDTMP, a potential bone pain palliation agent.

Máthé D, Balogh L, Polyák A, Király R, Márián T, Pawlak D, Zaknun JJ, Pillai MR, Jánoki GA.

Nucl Med Biol. 2010 Feb;37(2):215-26. doi: 10.1016/j.nucmedbio.2009.09.004. Epub 2009 Nov 12.

PMID:
20152721
20.

Comparison of the tumorigenic potential of liver and kidney tumors induced by N-nitrosodimethylamine.

Trencsenyi G, Juhasz T, Bako F, Marian T, Pocsi I, Kertai P, Hunyadi J, Banfalvi G.

Histol Histopathol. 2010 Mar;25(3):309-20. doi: 10.14670/HH-25.309.

PMID:
20054803

Supplemental Content

Loading ...
Support Center